JP5307969B2 - Life extension agent containing white rice-derived ingredients as active ingredients - Google Patents
Life extension agent containing white rice-derived ingredients as active ingredients Download PDFInfo
- Publication number
- JP5307969B2 JP5307969B2 JP2005516915A JP2005516915A JP5307969B2 JP 5307969 B2 JP5307969 B2 JP 5307969B2 JP 2005516915 A JP2005516915 A JP 2005516915A JP 2005516915 A JP2005516915 A JP 2005516915A JP 5307969 B2 JP5307969 B2 JP 5307969B2
- Authority
- JP
- Japan
- Prior art keywords
- rice
- product
- water
- white rice
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 100
- 235000009566 rice Nutrition 0.000 title claims description 100
- 239000004480 active ingredient Substances 0.000 title claims description 10
- 239000004615 ingredient Substances 0.000 title description 2
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims description 99
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 108090000790 Enzymes Proteins 0.000 claims description 54
- 102000004190 Enzymes Human genes 0.000 claims description 54
- 238000011282 treatment Methods 0.000 claims description 28
- 239000002994 raw material Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 230000004083 survival effect Effects 0.000 claims description 7
- 235000021329 brown rice Nutrition 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 239000000047 product Substances 0.000 description 72
- 229940088598 enzyme Drugs 0.000 description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 28
- 229920002472 Starch Polymers 0.000 description 25
- 230000000694 effects Effects 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 25
- 235000019698 starch Nutrition 0.000 description 25
- 239000008107 starch Substances 0.000 description 25
- 238000000855 fermentation Methods 0.000 description 23
- 230000004151 fermentation Effects 0.000 description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 230000002265 prevention Effects 0.000 description 17
- 238000000605 extraction Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- 230000006872 improvement Effects 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 238000000926 separation method Methods 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000000593 degrading effect Effects 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000002366 lipolytic effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000035784 germination Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 230000003301 hydrolyzing effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- 244000274847 Betula papyrifera Species 0.000 description 4
- 235000009113 Betula papyrifera Nutrition 0.000 description 4
- 235000009109 Betula pendula Nutrition 0.000 description 4
- 235000010928 Betula populifolia Nutrition 0.000 description 4
- 235000002992 Betula pubescens Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000007515 enzymatic degradation Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000132059 Carica parviflora Species 0.000 description 2
- 235000014653 Carica parviflora Nutrition 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- -1 facial cleansers Substances 0.000 description 2
- 210000001752 female genitalia Anatomy 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000000777 hematopoietic system Anatomy 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000005210 lymphoid organ Anatomy 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000000260 male genitalia Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 210000004560 pineal gland Anatomy 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010014190 Eczema asteatotic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000005926 Hamelia patens Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
Description
本発明は、白米由来成分を有効成分とする寿命延長剤に関するものである。 The present invention relates to a life extension agent containing a white rice-derived component as an active ingredient.
ヒトをはじめとする個体は、誰しも年を取りやがて死を迎えるという現実から回避できない状況下、通常、一年でも長生きすることを切望している。ところで、百薬の長といわれる酒は、適量であれば、人を陽気にさせてストレスを解消させる等、特に精神面に対して好影響を与えることが周知である。そして、ほどほどの酒は、当該ストレス解消を通じて、人を長生きさせると考えられている。ここで、酒の場合は、酒の中に含まれるアルコール(エチルアルコール)が、ストレス解消の有効成分であると考えられている。[特許文献1]特開2003−225080
しかしながら、上記のアルコールは、それ自体に直接的に寿命延長効果がある訳ではなく、その効果は間接的である。また、アルコールの酸化物は、有毒であるか又は効果が無いことが確認されている。しかも、継続的なアルコール摂取はアルコール依存症になりやすく、また、過剰のアルコール摂取はアルコール中毒に繋がる可能性もあり、いずれも、むしろ寿命を短縮させる結果となり得る。本発明は、エチルアルコールのような精神面に対して好影響を与えるという作用機序ではなく、個体や細胞等に直接働きかけてこれらの寿命を延長させる効果を奏する、生体安全性に優れた天然物由来の寿命延長剤を提供することを目的とする。Individuals, including humans, are anxious to live a long life, usually in a situation where no one can avoid the reality that everyone dies and dies. By the way, it is well known that alcohol, which is said to be the head of a hundred medicines, has a particularly positive effect on the mental aspect, such as making people cheerful and relieving stress. And moderate liquor is thought to make people live longer through relieving stress. Here, in the case of liquor, alcohol (ethyl alcohol) contained in liquor is considered to be an effective component for stress relief. [Patent Document 1] JP2003-225080A
However, the above-mentioned alcohol itself does not directly have a life extension effect, and the effect is indirect. Also, it has been confirmed that alcohol oxides are toxic or ineffective. Moreover, continuous alcohol consumption tends to be alcoholic, and excessive alcohol consumption can lead to alcoholism, both of which can rather result in a shortened lifespan. The present invention is not a mechanism of action that has a positive effect on the mental aspects such as ethyl alcohol, but has an effect of prolonging the life span by directly acting on individuals, cells, etc. An object is to provide a life-extending agent derived from a product.
これまでも本発明者らは、動植物合和すの観点から、主食であり安全性が最も高い白米を中心に様々な研究を進めている。それらの研究の途中で、偶然、当該原料に細胞レベルの顕著な寿命延長効果があることを発見し、このことを契機として組織や個体の寿命延長効果についても確認したところ、顕著な寿命延長効果を奏することを見出し、本発明に到達したものである。
本発明において、白米由来のどのような成分(又は複数の成分の組み合わせ、或いは所定存在比での複数の成分の組み合わせ)が寿命延長効果を有するのかに関しては、未だ解明されるに至っていないが、白米の水処理物{本発明(1)〜(4)}は、いずれも寿命延長効果を示すことが判明した。以下、本発明(1)〜(4)を列記する。
本発明(1)は、白米部分を必須的に含む米原料の水処理物に含まれる、エチルアルコール又はその酸化物以外の成分を有効成分とすることを特徴とする寿命延長剤である。
本発明(2)は、前記米原料が、白米、玄米、発芽米、白糠及びこれらの一種以上の組み合わせである、前記発明(1)の寿命延長剤である。
本発明(3)は、前記水処理物が、前記米原料の水抽出物、前記米原料又は前記水抽出物の澱粉加水分解処理物、前記米原料、前記水抽出物又は前記澱粉加水分解処理物の発酵物である、前記発明(1)又は(2)の寿命延長剤である。
本発明(4)は、前記水処理物が、澱粉加水分解酵素及び/又は麹で処理したものである、前記発明(1)〜(3)のいずれか一つの寿命延長剤である。Until now, the present inventors have been conducting various studies focusing on white rice, which is a staple food and has the highest safety, from the viewpoint of combining plants and animals. In the middle of these studies, we discovered that the raw material had a significant life-longening effect at the cellular level, and we confirmed the life-longening effect of tissues and individuals using this as an opportunity. The present invention has been found.
In the present invention, as to what component derived from white rice (or a combination of a plurality of components, or a combination of a plurality of components at a predetermined abundance ratio) has a life extending effect, it has not yet been elucidated. It was found that all the water-treated products of white rice {present inventions (1) to (4)} exhibited a life extension effect. Hereinafter, the present inventions (1) to (4) are listed.
The present invention (1) is a life extending agent characterized by comprising as an active ingredient a component other than ethyl alcohol or its oxide contained in a water-treated product of rice raw material that essentially contains a white rice portion.
This invention (2) is a life extension agent of the said invention (1) whose said rice raw material is white rice, brown rice, germinated rice, white rice bran, and 1 or more types of these combinations.
In the present invention (3), the water-treated product is an aqueous extract of the rice raw material, a starch hydrolyzed product of the rice raw material or the water extract, the rice raw material, the water extract or the starch hydrolyzed treatment. It is a life extension agent of the said invention (1) or (2) which is a fermented product.
The present invention (4) is the life extension agent according to any one of the inventions (1) to (3), wherein the water-treated product is treated with starch hydrolyzing enzyme and / or koji.
図1は、試験例1における本発明品を添加しなかった細胞の顕微鏡写真(14日間培養)である。ウェル底面に正常に接着できず、剥離している。
図2は、試験例1における本発明品を添加した細胞の顕微鏡写真(14日間培養)である。ウェル底面に正常に接着している。
ここで、本明細書における各用語の意味について説明する。尚、説明の都合上、一部の用語の意味については「発明を実施するための最良の形態」の箇所で述べることとする。まず、「水処理物」とは、水を用いた米原料の加工品を指し、例えば、米原料の水抽出物、水存在下での米原料の澱粉加水分解処理物(例えば、米原料に水を加えて澱粉加水分解処理を施したもの、米原料の水抽出物を澱粉加水分解処理したもの)、水存在下での米原料の発酵物(例えば、米原料に水を加えて発酵させたもの、米原料の水抽出物を発酵させたもの、米原料の水抽出物を澱粉加水分解処理したものを発酵させたもの)を包含する。また、ここでの「水」は、水を必須的に含んでいる水性媒体を意味し、例えば、水や水とエチルアルコールとの任意の割合の混合液を含む。「水抽出物」とは、物理的処理(例えば、圧搾、加熱処理)、化学的処理(例えば、酸やアルカリ処理)、生物的(生化学的)処理(例えば、麹、微生物処理、酵素処理)を単独又は組み合わせて施したものをいう。例えば、米原料に水を加えたもの、米原料を酸又はアルカリで処理したもの、米原料の加水物に酵素(例えば澱粉加水分解酵素)及び/又は麹を作用させたもの(抽出前又は抽出と同時)、或いは、これらの処理を加熱又は非加熱下でおこなったものである態様を挙げることができる。「澱粉加水分解処理物」とは、澱粉加水分解処理を施したものである限り特に限定されず、非分解澱粉を含有していてもよい。ここで、「澱粉加水分解処理」とは、澱粉及び/又はその分解物である多糖類を加水分解する処理であれば特に限定されず、例えば、酵素による処理や酸による処理を挙げることができる。「発酵」とは、アルコール発酵や有機酸発酵(例えば乳酸発酵)を単独で又は組み合わせて行うことを指す。「有機酸発酵」とは、例えば、乳酸発酵や酢酸発酵を指す。「有効成分として含有する」とは、寿命延長効果を奏する程度に当該成分を含有することを意味し、当該成分が寿命延長剤の一部を構成する場合のみならず、当該成分が寿命延長剤のすべてを構成する場合を含む。「寿命延長剤」とは、投与した場合としない場合とを比較して、細胞、組織、臓器又は個体の寿命が延長される薬剤を意味する。ここで、細胞、組織、臓器又は個体に係る生命体は、多細胞生物(ヒトを含む哺乳類といった高等動物も含む)及び単細胞生物を指す。「エチルアルコール又はその酸化物以外の」とは、有効成分がエチルアルコールやその酸化物とは異なるという意味であり、エチルアルコールやその酸化物が含まれていても本件発明から除外されるとは限らない。尚、エチルアルコール又はその酸化物が含まれている製品が本発明の範囲に属するか否かを決定する際には、当該製品からエチルアルコールやその酸化物を除去したものとしないものとの両方について前記試験を行い、除去したものについて上記規定の効果を奏した場合、当該エチルアルコール又はその酸化物含有製品は本件発明の範囲内とする。FIG. 1 is a photomicrograph (cultured for 14 days) of cells to which the product of the present invention was not added in Test Example 1. It cannot be properly bonded to the bottom of the well and is peeled off.
FIG. 2 is a photomicrograph (14-day culture) of cells to which the product of the present invention was added in Test Example 1. It adheres normally to the bottom of the well.
Here, the meaning of each term in this specification is explained. For convenience of explanation, the meaning of some terms will be described in the section “Best Mode for Carrying Out the Invention”. First, “water-treated product” refers to a processed product of rice raw material using water. For example, a water extract of rice raw material, a starch hydrolyzed product of rice raw material in the presence of water (for example, rice raw material) Starch hydrolyzed with water added, rice hydrolyzed rice starch hydrolyzed starch, fermented rice raw material in the presence of water (eg, water added to rice fermented) Rice, fermented water extract of rice raw material, and fermented water extract of rice raw material hydrolyzed with starch). In addition, “water” here means an aqueous medium that essentially contains water, and includes, for example, water or a mixed liquid of an arbitrary ratio of water and ethyl alcohol. “Water extract” means physical treatment (for example, pressing, heat treatment), chemical treatment (for example, acid or alkali treatment), biological (biochemical) treatment (for example, sputum, microbial treatment, enzyme treatment). ) Is used alone or in combination. For example, rice raw material with water, rice raw material treated with acid or alkali, rice raw material hydrolyzed with enzyme (eg starch hydrolyzing enzyme) and / or koji (before or after extraction) Or an embodiment in which these treatments are performed under heating or non-heating. The “starch hydrolyzed product” is not particularly limited as long as it has been subjected to starch hydrolysis treatment, and may contain non-degraded starch. Here, the “starch hydrolysis treatment” is not particularly limited as long as it is a treatment that hydrolyzes starch and / or polysaccharides that are degradation products thereof, and examples thereof include an enzyme treatment and an acid treatment. . “Fermentation” refers to performing alcoholic fermentation or organic acid fermentation (for example, lactic acid fermentation) alone or in combination. “Organic acid fermentation” refers to, for example, lactic acid fermentation or acetic acid fermentation. “Contained as an active ingredient” means containing the component to the extent that it has a life extending effect, and not only when the component constitutes a part of the life extending agent, but the component is also a life extending agent. Including all of the above. “Life extension agent” means an agent that extends the life of a cell, tissue, organ or individual compared to when it is administered or not. Here, the living organisms related to cells, tissues, organs or individuals refer to multicellular organisms (including higher animals such as mammals including humans) and unicellular organisms. “Other than ethyl alcohol or its oxide” means that the active ingredient is different from ethyl alcohol or its oxide, and even if ethyl alcohol or its oxide is included, it is excluded from the present invention. Not exclusively. It should be noted that when determining whether a product containing ethyl alcohol or its oxide belongs to the scope of the present invention, both the product obtained by removing ethyl alcohol or its oxide from the product or not. In the case where the above-mentioned effect is obtained with respect to the product that has been subjected to the test and removed, the ethyl alcohol or its oxide-containing product is within the scope of the present invention.
本発明に係る「白米部分を必須的に含む米原料」とは、白米の少なくとも一部を含む限り特に限定されず、例えば、白米、玄米及び発芽させた米といった米だけでなく、白糠のみ、白糠と赤糠とのブレンドも含む概念である。ここで、白米及び玄米に関しては、ジャポニカ、インディカ米を問わず、うるち米や餅米等の玄米及び白米を指し、品種、種類は問わない。また、白糠とは、一般に、精白時に出てくる92%以下の白糠を指し、この範囲内の一部を原料として用いればよい(例えば、92%以下の白糠すべて、92〜80%の白糠のみ、60%以下の白糠)。赤糠とは、一般に、92%以上の赤糠を指す。尚、有効成分は、熱及び光に対して安定であるため、上記の原料は、浸漬、蒸煮、焙煎(砂焙り、網焙り、熱風焙煎等全てを指す)、蒸煮焙煎、凍結乾燥等の表面変性、UV照射等の光変性、パットライス等の加圧焙煎、揚げる等の原料処理をしてもよい。
発芽させた米を製造する場合、胚芽のついた米を水に浸漬或いは水を噴霧して発芽させる。発芽させる時の温度は5〜70℃である。但し、発芽さえすれば、温度及び時間は問わない。また、発芽中に水が腐敗する危険性がある場合は、腐敗しないように水を取り替えるか、何らかの防腐を行うのが好ましい。ここで、発芽とは、発芽する直前から発芽したものまで全てを指す。この発芽させた米をよく洗浄して用いる。この時、乾燥して用いてもよい。
水処理(例えば、水抽出)の際、米原料は顆粒又は粉体状であることが好適である。尚、顆粒又は粉体状でない場合には、処理時間を長くする。以下、水処理物の各態様について説明する。
まず、水抽出物について詳述する。米原料を水抽出する場合、抽出温度は、高温が効率的であるが、低温でも十分に抽出を行うことができる。但し、40℃以下の低温の場合は、pHを酸性或いはアルカリ性にするか、防腐剤或いはエチルアルコールを加えて、米原料が腐敗しないように処理することが望ましい。抽出時間は、有効成分さえ抽出できれば、長くても短くてもよく、抽出温度により定めればよい。また、水抽出は、加圧下又は常圧下で行っても、減圧下で行ってもよい。水抽出の場合、最も問題になるのは糊化現象である。糊状になれば、抽出効率が悪くなるばかりでなく、実作業においては困難を極める。これを防ぐためには、アミラーゼを加えて反応させるか、塩酸等で酸性にして澱粉を分解すればよく、この方法を用いることにより、十分に解決でき、実用上も全く問題はない。
水抽出物中の有効成分は、酸、アルカリに安定であるので、酸分解抽出又はアルカリ分解抽出を行うのも有効である。この場合、必要により中和、脱塩を行う。また、米原料を酵素分解及び/又は麹を作用させてもよい。ここでいう酵素分解とは、澱粉加水分解酵素(液化酵素、糖化酵素)、蛋白分解酵素、脂肪分解酵素、繊維分解酵素、リグニン分解酵素、ペクチン分解酵素等米に働く酵素を1種又は2種以上作用させることをいう。例えば、液化酵素と糖化酵素との組み合わせを挙げることができる。また、麹として麹菌の種類及び米の品種、種類は問わない。尚、抽出を行うに際し、酵素や麹を作用させるタイミングは、抽出の前又は抽出と同時のいずれでもよい。
次に、澱粉加水分解処理物について詳述する。当該澱粉加水分解処理物は、好適には、水の存在下で米原料に澱粉加水分解酵素及び/又は麹を作用させるか、または、前記抽出物に澱粉加水分解酵素及び/又は麹を作用させたものである。当該澱粉加水分解は、上記処理(水抽出処理)の後に限られず、これと同時に行ってもよい。また、麹は、上記同様、麹菌の種類及び米の品種や種類は問わない。また、前記抽出物に澱粉加水分解酵素を作用させる態様には、前記抽出物自体が既に部分的に澱粉加水分解されているものも含む(例えば、抽出段階で液化酵素を使用している場合)が、これは、当該部分澱粉加水分解物を更に加水分解させることを意味する。
次に、発酵物について詳述する。当該発酵物は、水の存在下で米原料を発酵させるか、前記水抽出物を発酵させるか、又は、前記澱粉分解処理物を発酵させたものである。ここで、当該発酵は、アルコール発酵や有機酸発酵(乳酸発酵等)を指し、また、当該発酵は、上記処理(水抽出処理、澱粉分解処理)の後に限られず、これと同時に行ってもよい。ここで、アルコール発酵法に関しては、より高い寿命延長効果を奏するには、清酒の製造方法である並行複発酵よりも、単行複発酵の方が好適である。尚、エチルアルコール自体は、摂取しすぎると寿命延長効果が無いだけでなくむしろ寿命延長の阻害効果が確認されているので、存在しない方がよい。但し、有効成分が存在している以上、寿命延長効果が多少下がる程度であるので、エチルアルコールが存在する態様も本発明に属する。尚、酵母による通気発酵、エチルアルコール沈澱等を行なって除糖してもよい。また、有機酸発酵を行うと、更に寿命延長効果が高まる。特に、乳酸発酵が好適である。
以上のようにして得られた本発明に係る寿命延長剤は、残渣と分離することなくそのままの状態で、或いは、圧搾や濾過を行った後、対象物(細胞、組織、臓器又は個体)に適用する。ここで、そのまま用いるときは、殺菌或いは除菌を行うことが好適である。本発明に係る寿命延長剤は、例えば個体に適用する場合、内用でも外用でもよい。具体的には、実際の用途に応じ、常法にしたがってクリーム、洗顔料、乳液、化粧水、クレンジング、パック、石鹸等の化粧料、軟膏剤、パスタ剤、ローション剤、チンキ剤、リエメント剤、ゼリー剤、エアゾール剤、液剤、ゼリー剤、エリキシル剤、カプセル剤(軟カプセル剤、硬カプセル剤)、顆粒剤、丸剤、懸濁剤、乳剤、散剤、細粒剤、錠剤、シロップ剤、注射剤、トローチ剤、リモナーデ剤等の経口剤、注射剤等の剤型で用いる。更には、食品や飲料に添加する処方も含む。また、入浴剤の形態で使用してもよい。尚、用途に応じ、他の配合成分や薬剤を添加してもよい。ヒトに投与する場合の投与量は、使用者の年齢、体重や重篤度等にもよるが、例えば、体重1kg当たり、一日0.01〜20mlである。また、製品製造においては、例えば、製品100重量部当たり、本発明品を0.1〜30重量部添加する。
尚、実際の製品との関係では、例えば、寿命延長のために用いられるものである旨の表示を製品(例えば、薬剤、化粧品、飲食品)のパッケージ、パンフレット及び取扱説明書等に付した態様が好適である。このような表示を付することにより、本発明品がそのような効果を奏することが、ユーザーに一目瞭然となる。加えて、他の法律(薬事法)の制限により、製品等に直接表示できない場合には、例えば、インターネットや新聞記事等の形で当該製品の効能をユーザーに間接的に告知する手法や、営業が口頭で当該効能をユーザーに告知する手法も想定される。したがって、「寿命延長のために用いられるものである旨の表示」には、これらの手法も含め、寿命延長を明記した場合のみならず、寿命延長を示唆する表示や行為も包含される。また、寿命延長効果としては、試験例1においてはいずれかの培養日数において、コントロールに対して生存率が10%程度上昇することが好適であり、30%程度上昇することがより好適であり、50%程度上昇することが最も好適である。また、試験例2においては、コントロールに対して平均寿命が5%程度上昇することが好適であり、10%程度上昇することがより好適であり、20%程度上昇することが最も好適である。The `` rice raw material essentially containing a white rice portion '' according to the present invention is not particularly limited as long as it contains at least a portion of white rice, for example, not only rice such as white rice, brown rice and germinated rice, but only white rice bran, It is a concept that includes a blend of white rabbit and red rabbit. Here, with respect to white rice and brown rice, it refers to brown rice and white rice such as glutinous rice and glutinous rice, regardless of japonica and indica rice, and any kind and kind. The white birch generally refers to 92% or less of white birch that appears at the time of whitening, and a portion within this range may be used as a raw material (for example, all 92% or less of white birch, 92-80% of white birch only) 60% or less white rabbit). Red coral generally refers to red coral of 92% or more. In addition, since the active ingredient is stable to heat and light, the above-mentioned raw materials are immersed, steamed, roasted (points to all of sand roasting, net roasting, hot air roasting, etc.), steaming roasting, freeze drying It may be subjected to raw material treatment such as surface modification such as UV irradiation, photo-modification such as UV irradiation, pressure roasting such as Patrice, frying.
When producing germinated rice, germinated rice is immersed in water or sprayed with water. The temperature at the time of germination is 5-70 degreeC. However, temperature and time are not limited as long as germination occurs. In addition, when there is a risk of water rot during germination, it is preferable to replace the water so that it does not rot or to perform some preservative. Here, germination refers to everything from just before germination to germination. The germinated rice is washed thoroughly before use. At this time, you may dry and use.
In the water treatment (for example, water extraction), the rice material is preferably in the form of granules or powder. In addition, when it is not a granule or powder form, processing time is lengthened. Hereinafter, each aspect of the water treatment product will be described.
First, the water extract will be described in detail. When the rice raw material is extracted with water, a high extraction temperature is efficient, but the extraction can be sufficiently performed even at a low temperature. However, in the case of a low temperature of 40 ° C. or lower, it is desirable that the pH is made acidic or alkaline, or a preservative or ethyl alcohol is added so that the rice raw material is not spoiled. The extraction time may be long or short as long as the active ingredient can be extracted, and may be determined by the extraction temperature. Moreover, water extraction may be performed under pressure, a normal pressure, or under reduced pressure. In the case of water extraction, the most serious problem is the gelatinization phenomenon. If it becomes paste-like, not only extraction efficiency will worsen but it will be extremely difficult in actual work. In order to prevent this, the starch may be decomposed by adding amylase to react or acidifying with hydrochloric acid or the like. By using this method, it can be solved sufficiently and there is no problem in practical use.
Since the active ingredient in the water extract is stable to acid and alkali, it is also effective to perform acid decomposition extraction or alkali decomposition extraction. In this case, neutralization and desalting are performed as necessary. Further, the rice raw material may be subjected to enzymatic degradation and / or koji. As used herein, enzymatic degradation refers to one or two types of enzymes that act on rice, such as starch hydrolyzing enzymes (liquefaction enzymes, saccharifying enzymes), proteolytic enzymes, lipolytic enzymes, fiber-degrading enzymes, lignin-degrading enzymes, and pectin-degrading enzymes. That means the above action. For example, the combination of a liquefying enzyme and a saccharifying enzyme can be mentioned. In addition, the type of koji mold, rice varieties and types are not limited. In addition, when performing extraction, the timing which acts an enzyme or a koji may be either before extraction or simultaneously with extraction.
Next, the starch hydrolyzed product will be described in detail. The starch hydrolyzed product preferably has a starch hydrolyzing enzyme and / or koji acting on rice ingredients in the presence of water, or a starch hydrolyzing enzyme and / or koji acting on the extract. It is a thing. The starch hydrolysis is not limited to the above treatment (water extraction treatment), and may be performed at the same time. In addition, as for the koji, the kind of koji mold and the variety and kind of rice are not limited. The embodiment in which starch hydrolase is allowed to act on the extract includes those in which the extract itself is already partially hydrolyzed with starch (for example, when a liquefaction enzyme is used in the extraction stage). However, this means that the partial starch hydrolyzate is further hydrolyzed.
Next, the fermented product will be described in detail. The fermented product is obtained by fermenting rice raw materials in the presence of water, fermenting the water extract, or fermenting the starch decomposition product. Here, the fermentation refers to alcohol fermentation or organic acid fermentation (lactic acid fermentation or the like), and the fermentation is not limited to the above treatment (water extraction treatment, starch decomposition treatment), and may be performed at the same time. . Here, with respect to the alcohol fermentation method, in order to achieve a higher life extension effect, single-line double fermentation is preferable to parallel double-fermentation, which is a method for producing sake. It should be noted that ethyl alcohol itself should not be present because it not only has no life-extending effect when it is taken too much, but rather has an inhibitory effect on life extension. However, as long as the active ingredient is present, the effect of extending the life is somewhat reduced, so that an embodiment in which ethyl alcohol is present also belongs to the present invention. Sugar may be removed by aeration fermentation with yeast, precipitation with ethyl alcohol, or the like. Moreover, when organic acid fermentation is performed, the lifetime extending effect is further enhanced. In particular, lactic acid fermentation is suitable.
The life extension agent according to the present invention obtained as described above is applied to an object (cell, tissue, organ or individual) as it is without being separated from the residue or after being squeezed or filtered. Apply. Here, when used as it is, it is preferable to perform sterilization or sterilization. The life extension agent according to the present invention may be used internally or externally, for example, when applied to an individual. Specifically, according to the actual application, according to conventional methods, cosmetics such as creams, facial cleansers, emulsions, lotions, cleansings, packs, soaps, ointments, pasta agents, lotions, tinctures, ligaments, Jelly, aerosol, liquid, jelly, elixir, capsule (soft capsule, hard capsule), granule, pill, suspension, emulsion, powder, fine granule, tablet, syrup, injection It is used in oral dosage forms such as pills, troches and limonades, and in dosage forms such as injections. Furthermore, the prescription added to a foodstuff and a drink is also included. Moreover, you may use it with the form of a bath agent. In addition, you may add another compounding component and a chemical | medical agent according to a use. The dose when administered to a human depends on the age, weight, severity, etc. of the user, but is, for example, 0.01-20 ml per kg of body weight per day. Moreover, in product manufacture, 0.1-30 weight part of this invention products are added per 100 weight part of products, for example.
In relation to the actual product, for example, an indication that the product is used for extending the life of the product, such as a drug, a cosmetic, a food and drink package, a pamphlet, and an instruction manual. Is preferred. By attaching such a display, it is obvious to the user that the product of the present invention has such an effect. In addition, if it cannot be displayed directly on the product due to restrictions of other laws (Pharmaceutical Affairs Law), for example, a method of indirectly informing the user of the effectiveness of the product in the form of the Internet or newspaper articles, etc. A method of verbally notifying the user of the effect is also assumed. Therefore, the “indication to be used for extending the life” includes not only the case where the life extension is specified, but also the indication and action suggesting the life extension including these methods. Further, as the life extension effect, in Test Example 1, in any culture days, it is preferable that the survival rate is increased by about 10% relative to the control, more preferably by about 30%, Most preferably, it rises by about 50%. In Test Example 2, the average life is preferably increased by about 5% relative to the control, more preferably by about 10%, and most preferably by about 20%.
[実施例1]
白米を粉砕機にかけ、白米の粉砕物500gを得た。この粉砕物に液化酵素10gと水1500mLを添加した。その後、徐々に温度を上げていき5分間煮沸抽出した後、冷却した。その後、絞り機で絞り、本発明品を得た。
[実施例2]
白米を粉砕機にかけ白米の粉砕物を500gを得た。この粉砕物に米麹300gと水1500mLを添加し、55℃で20時間放置した。その後絞り機で絞り、本発明品を得た。
[実施例3]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に糖化酵素(グルコアミラーゼ)5gと水3Lを添加し、55℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。
[実施例4]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に蛋白質分解酵素5gと水3Lを添加し、50℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.3Lを得た。
[実施例5]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと繊維分解酵素5gと水3Lを添加し、50℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.2Lを得た。
[実施例6]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと脂肪分解酵素5gと水3Lを添加し、50℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.1Lを得た。
[実施例7]
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物に液化酵素10gと水1500mLを添加した。その後、徐々に温度を上げていき、該酵素を作用させた後、5分間煮沸抽出し、冷却した。抽出物を絞り機で絞り、本発明品1420mLと残渣500gを得た。
[実施例8]
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、糖化酵素2g、ペクチン分解酵素2gと水1500mLを添加し、50℃で20時間放置した。その後、徐々に温度を上げていき5分間煮沸抽出した後冷却した。抽出物を絞り機で絞り、本発明品1470mLと残渣450gを得た。
[実施例9]
精白歩合50〜70%の特白糠490g、92%以上の赤糠10gに、タンパク質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、糖化酵素2g、ペクチン分解酵素2gと水1500mLを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品1400mLと残渣550gを得た。
[実施例10]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、糖化酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.6Lを得た。
[実施例11]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、麹50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.6Lを得た。
[実施例12]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、蛋白質分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。
[実施例13]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後脂肪分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。
[実施例14]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、繊維分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。
[実施例15]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に1/10N塩酸3Lを添加し、よく撹拌し24時間放置した。その後、濾過器を用いて固液分離を行い、苛性ソーダで中和し、2.3Lの抽出液を得た。
[実施例16]
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に95%エタノール3Lを添加し、よく撹拌し4日間放置した。その後、濾過器を用いて固液分離を行い、2Lの抽出液を得た。このろ液に水4Lを加え、ロータリーエバポレーターでエタノールを留去し2Lとした。
[実施例17]
実施例2で得た米エキス1500mLに酵母を添加し、7日間アルコール発酵を行なった。その後、濾過器で酵母を濾別し、本発明品を得た。
[実施例18]
実施例1で得た米エキス1500mLに乳酸菌を添加し、2日間乳酸発酵を行なった。その後、濾過器で乳酸菌を濾別し、本発明品を得た。
[実施例19]
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、糖化酵素2g、ペクチン分解酵素2gと水1500mLを添加し、50℃で20時間放置した。その後徐々に温度を上げていき5分間煮沸抽出した後冷却した。この酵素分解抽出物に酵母を添加し、7日間アルコール発酵した。その後、絞り機で絞り、本発明品を得た。
[実施例20]
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、糖化酵素2g、ペクチン分解酵素2gと水1500mLを添加し、50℃で20時間放置した。その後徐々に温度を上げていき5分間煮沸抽出した後冷却した。この酵素分解抽出物に乳酸菌を添加し、2日間乳酸発酵した。その後、絞り機で絞り、本発明品を得た。
[実施例21]
白米を粉砕機にかけ、白米の粉砕物500gを得た。この粉砕物に液化酵素10gと水1500mLを添加した。その後、徐々に温度を上げていき、該酵素を作用させた後、5分間煮沸抽出し、冷却した。これに95%エタノール100mLを添加し、20日間酢酸発酵を行なった。その後ろ過し、本発明品1400mLを得た。
試験例1
方法:コンフルエントに培養した小腸粘膜上皮細胞(IEC−6)を、1%試料を添加した培養液で30日間培養し、細胞の30日間生存率を調べた。試料添加後、培地交換は行わなかった。なお、容器は6wellプレート(NUNC)、培地はGIT培地(日本製薬(株))を用い、通常の5%炭酸ガス、36.5℃で培養した。
試料:実施例1、10、18
結果:14日間培養した後のIEC−6を観察した結果、本発明品を添加した細胞は異常が全く認められず、正常な状態を維持し生存し続けていることが判明した。一方本発明品を添加しなかった細胞(コントロール)では、死滅した細胞が認められた(一例として14日間培養後のコントロール細胞及び実施例1を添加した細胞の顕微鏡写真をそれぞれ図1及び図2に示す)。さらに30日間培養した後のIEC−6を観察した結果、本発明品を添加した細胞はやはり異常が全く認められず、正常な状態を維持し生存し続けていることが判明した。一方、試料を添加しなかった細胞では、生存し続けることができなかった。各試料における細胞の30日間生存率を表1に示す。
表1のとおり、本発明品を添加した培地で培養した細胞の30日間生存率は85%以上であり、通常の培地のみで培養した細胞の30日間生存率は0%で全て死滅していた。以上の試験より本発明品による寿命延長効果が実証された。コントロールは、14日目程度より死滅が始めるため、一般的には週に2回培養液を交換している。従って本発明品は、寿命延長効果のみならず、細胞を使った実験にも多大な貢献をするものである。尚、30日後の細胞は癌化しているものではなかった。また、細胞の形態は正常であった。
試験例2
実験動物を用いて本発明を摂食させたグループと摂食させないグループについて寿命を調査し、本発明の寿命延長効果を調べた。
方法:
4週齢の雄性BALB/a系マウス10匹を一匹ずつ個別にケージに入れ、通常の食餌、飲水を自由にさせた状態で35週齢まで予備飼育した。その後(35週令以降は)、10匹中5匹は、予備飼育後、通常の餌に本発明品を0.6%(v/w)配合した餌を与え、残りの5匹は通常の餌を与え、各々死亡するまで飼育し、寿命を測定した。
試料:実施例1
結果:
長期飼育試験の結果、本発明品配合の餌を与えたBALB/a系マウス(本発明品群)は、67、129、87、100、92週まで生存した。一方、通常の餌を与えたBALB/a系マウス(コントロール群)は、78、84、80、64、60週まで生存した。本発明群の平均寿命は95週、コントロール群の平均寿命は73.2週であり、本発明品を与えたマウスは、与えなかったマウスと比較して平均寿命が約30%長かった。これより、本発明による寿命延長効果が動物においても証明された。[Example 1]
The white rice was put into a pulverizer to obtain 500 g of pulverized white rice. 10 g of liquefied enzyme and 1500 mL of water were added to the pulverized product. Thereafter, the temperature was gradually raised, boiling and extracting for 5 minutes, and then cooled. Then, it squeezed with the squeezer and obtained the product of the present invention.
[Example 2]
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 300 g of rice bran and 1500 mL of water were added and left at 55 ° C. for 20 hours. Thereafter, the product was squeezed with a squeezer to obtain the product of the invention.
[Example 3]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of saccharifying enzyme (glucoamylase) and 3 L of water were added and left at 55 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate.
[Example 4]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of proteolytic enzyme and 3 L of water were added and allowed to stand at 50 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.3 L of a filtrate.
[Example 5]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme, 5 g of fiber-degrading enzyme and 3 L of water were added and left at 50 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.2 L of a filtrate.
[Example 6]
The white rice was put into a grinder to obtain 1 kg of white rice grind. 5 g of liquefied enzyme, 5 g of lipolytic enzyme, and 3 L of water were added to this pulverized product, and the mixture was allowed to stand at 50 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.1 L of a filtrate.
[Example 7]
White rice was pulverized to obtain 500 g of pulverized white rice. 10 g of liquefied enzyme and 1500 mL of water were added to the pulverized product. Thereafter, the temperature was gradually raised and the enzyme was allowed to act, followed by boiling extraction for 5 minutes and cooling. The extract was squeezed with a squeezer to obtain 1420 mL of the product of the present invention and 500 g of residue.
[Example 8]
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of saccharifying enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiling and extracting for 5 minutes, and then cooled. The extract was squeezed with a squeezer to obtain 1470 mL of the product of the present invention and 450 g of residue.
[Example 9]
2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of saccharifying enzyme, 2 g of pectin degrading enzyme and 1500 mL of water are added to 490 g of white koji of 50 to 70% of whitening ratio and 10 g of red koji of 92% or more It was left at 20 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, cooled to 30 ° C., and squeezed with a squeezer to obtain 1400 mL of the present product and 550 g of a residue.
[Example 10]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating and cooling, 5 g of saccharifying enzyme was added, and the mixture was allowed to stand at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.6 L of a filtrate.
[Example 11]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating up and cooling, 50g of soot was added and it was left to stand at 55 degreeC for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.6 L of a filtrate.
[Example 12]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating up and cooling, 5 g of proteolytic enzymes were added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate.
[Example 13]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of lipolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate.
[Example 14]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating up and cooling, 5 g of fiber-degrading enzymes were added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate.
[Example 15]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 3 L of 1 / 10N hydrochloric acid was added, stirred well and allowed to stand for 24 hours. Thereafter, solid-liquid separation was performed using a filter and neutralized with caustic soda to obtain 2.3 L of an extract.
[Example 16]
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 3 L of 95% ethanol was added, stirred well and left for 4 days. Thereafter, solid-liquid separation was performed using a filter to obtain a 2 L extract. 4 L of water was added to the filtrate, and ethanol was distilled off with a rotary evaporator to 2 L.
[Example 17]
Yeast was added to 1500 mL of the rice extract obtained in Example 2, and alcohol fermentation was performed for 7 days. Thereafter, the yeast was separated by a filter to obtain the product of the present invention.
[Example 18]
Lactic acid bacteria were added to 1500 mL of the rice extract obtained in Example 1, and lactic acid fermentation was performed for 2 days. Thereafter, lactic acid bacteria were filtered off with a filter to obtain a product of the present invention.
[Example 19]
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of saccharifying enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised and the mixture was boiled and extracted for 5 minutes and then cooled. Yeast was added to this enzymatic degradation extract, and alcohol fermentation was performed for 7 days. Then, it squeezed with the squeezer and obtained the product of the present invention.
[Example 20]
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of saccharifying enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised and the mixture was boiled and extracted for 5 minutes and then cooled. Lactic acid bacteria were added to this enzymatic degradation extract, and lactic acid fermentation was performed for 2 days. Then, it squeezed with the squeezer and obtained the product of the present invention.
[Example 21]
The white rice was put into a pulverizer to obtain 500 g of pulverized white rice. 10 g of liquefied enzyme and 1500 mL of water were added to the pulverized product. Thereafter, the temperature was gradually raised and the enzyme was allowed to act, followed by boiling extraction for 5 minutes and cooling. To this was added 100 mL of 95% ethanol, and acetic acid fermentation was performed for 20 days. Thereafter, filtration was performed to obtain 1400 mL of the present product.
Test example 1
Method: Intestinal mucosal epithelial cells (IEC-6) cultured confluently were cultured in a culture medium supplemented with a 1% sample for 30 days, and the survival rate of the cells was examined for 30 days. The medium was not changed after the sample was added. The vessel was cultured at a normal 5% carbon dioxide gas at 36.5 ° C. using a 6-well plate (NUNC) and a medium using GIT medium (Nippon Pharmaceutical Co., Ltd.).
Sample: Examples 1, 10, 18
Result: As a result of observing IEC-6 after culturing for 14 days, it was found that the cells to which the product of the present invention was added had no abnormality and maintained a normal state and continued to survive. On the other hand, in the cells to which the product of the present invention was not added (control), dead cells were observed (for example, micrographs of the control cells after 14 days of culture and the cells to which Example 1 was added were respectively shown in FIGS. To show). As a result of observing IEC-6 after further culturing for 30 days, it was found that the cells to which the product of the present invention was added did not show any abnormality, and maintained a normal state and continued to survive. On the other hand, the cells to which no sample was added could not continue to survive. Table 1 shows the 30-day viability of the cells in each sample.
As shown in Table 1, the 30-day survival rate of the cells cultured in the medium to which the product of the present invention was added was 85% or more, and the 30-day survival rate of the cells cultured only in the normal medium was 0% and all were killed. . From the above test, the life extension effect by the product of the present invention was proved. Since the control begins to die from about the 14th day, the culture medium is generally changed twice a week. Therefore, the product of the present invention greatly contributes not only to the life extension effect but also to experiments using cells. The cells after 30 days were not cancerous. The cell morphology was normal.
Test example 2
Using experimental animals, the lifespan of the group fed with the present invention and the group not fed with the present invention were investigated, and the life extension effect of the present invention was examined.
Method:
Ten 4-week-old male BALB / a mice were individually placed in cages and preliminarily raised to 35-week-old with normal food and water ad libitum. Thereafter (after 35 weeks of age), 5 out of 10 animals were pre-bred and then fed a normal diet containing 0.6% (v / w) of the product of the present invention, and the remaining 5 animals were normal They were fed until they died and the life span was measured.
Sample: Example 1
result:
As a result of the long-term rearing test, BALB / a mice (product group of the present invention) fed with the diet of the product of the present invention survived to 67, 129, 87, 100, and 92 weeks. On the other hand, BALB / a mice (control group) fed with normal food survived to 78, 84, 80, 64, and 60 weeks. The average life span of the present invention group was 95 weeks, and the average life span of the control group was 73.2 weeks. The mice given the product of the present invention had an average life span of about 30% longer than those not given. From this, the life extension effect by this invention was proved also in the animal.
本発明によれば、ヒト等の個体に投与した場合に、細胞の寿命が延長され、細胞から構成される各種細胞群(組織や臓器)の寿命が延長され、ひいては、体全体(個体)の寿命が延長されるという効果を奏する。そして、個体を構成する細胞等に関し、細胞機能、細胞活性、細胞周期、若々しさ、遺伝子機能の正常化をもたらし、更には、個体を構成する器官・臓器・組織・体液に関しても、機能の向上若しくは改善、正常化、健全化、老化防止、若々しさ保持又は若返りをもたらす。更に、これらの結果として、多くの疾病の予防・治癒効果をもたらす。例えば、循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)等の機能の向上又は改善、正常化、健全化、老化防止、若々しさ保持或いは若返り;生命体或いは個体、器官、臓器、組織、体液又は細胞等における疾患及び諸症状の予防、悪化防止、改善、治療;循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)等における疾患及び諸症状の予防、悪化防止、改善、治療;表皮・真皮に起因する皮膚障害、細胞障害、DNA障害、アトピー性皮膚炎、ドライスキン等の乾燥性皮膚症状(アトピー皮膚、乾燥・ソゾウ化皮膚、老化皮膚、魚鱗癬、かさかさ肌、荒れ肌、皮脂欠乏症、乾皮症、乾燥性湿疹、進行性手掌角皮症、紅斑、硬化・角化、亀裂、鱗屑、紋理、痒み、掻瘢痕)、シミ、ソバカス、掻痒症、あせも、荒れ性、しもやけ、ひび、あかぎれ、皮膚老化症状(しわ、ハリ・弾力の低下、たるみ、シミ)、油性肌、ニキビ、色素異常症、紫外線による皮膚障害(シミ、ソバカス)、光炎症、くすみ、黒ずみ、物理・化学的皮膚障害(切り傷、火傷、床ずれ)、水、石けん、洗剤、界面活性剤、溶媒の使用により引き起こされる皮膚症状、皮膚外用剤等の医薬品の副作用、生物的皮膚障害(皮膚感染症)、水虫、皮膚炎、湿疹、創傷治癒、育毛、養毛、発毛、脱毛症等の予防、悪化防止、改善、治療;シミ、ソバカス、老人性色素斑等の予防、悪化防止、改善、治療;各種炎症、感染症、アレルギー、免疫機能障害、粘膜障害、細胞障害、DNA障害、腫瘍、潰瘍、高脂血症、肥満、糖尿病、動脈硬化、痛風、血圧の健全化、改善(高血圧、低血圧)、ボケ、痴呆症、鼻炎、喘息、目の諸症状、風邪、血管障害、うちみ、肩こり、くじき、神経痛、腰痛、リウマチ、痔、疲労回復、産前産後の冷え症、口内炎、のどの炎症、痛み、咽頭炎、喉頭炎、扁桃炎、歯周炎、歯槽膿漏、歯肉炎、骨粗鬆症、滋養強壮、虚弱体質、肉体疲労、体力低下、塩害防止、ヘリコバクターピロリ生育阻止、ストレス、医薬品による副作用等の予防、悪化防止、改善、治療;腫瘍の予防、悪化防止、改善;癌予防、悪化防止、進行抑制、転移防止、改善、治療;性機能の向上、改善、正常化、健全化又は老化防止、若々しさ保持或いは若返りが期待できる。更に、臓器保存剤や細胞保存剤(例えば培地の添加剤として使用)としても有用である。
また、白米は、食用以外に新規な利用用途はほとんど開発されていなかった。更に、白米は、主食として毎日摂取しても危険視する向きも無く、安全性も実証されている。すなわち、本発明は、非常に優れた寿命延長効果を持っているばかりでなく、安全性も十分に実証されているものを見出したものであり、さまざまな医薬品、医薬部外品、化粧品、食品等に利用できる非常に有意義な発明といえる。また、米の過剰生産といわれている現在、新たな米の利用用途を見出したことと、米のイメージアップによる消費拡大を図り得ることは、極めて有意義なことである。According to the present invention, when administered to an individual such as a human, the lifespan of the cells is extended, and the lifespan of various cell groups (tissues and organs) composed of the cells is extended. There is an effect that the life is extended. In addition, cell functions, cell activity, cell cycle, youthfulness, normalization of gene functions are brought about with respect to cells constituting an individual, and further, functions of organs, organs, tissues, and body fluids constituting an individual are also improved. Improves or improves, normalizes, restores health, prevents aging, maintains youthfulness or rejuvenates. Furthermore, as a result of these, many diseases are prevented and cured. For example, circulatory system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue / organ, spleen, thymus), skin, skin appendages, digestive system (lip, tonsils, teeth, esophagus, stomach) , Small intestine, large intestine, liver, biliary system, spleen), respiratory system (nose, pharynx, larynx, trachea, lung), urinary system (kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine system (Pituitary gland, pineal gland, thyroid gland, adrenal gland), brain, nervous system (peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism), balance / hearing apparatus, visual instrument, each mucous system, motor organ (Bone, joints, muscles, tendons, ligaments) function improvement or improvement, normalization, health, anti-aging, youthfulness retention or rejuvenation; life forms or individuals, organs, organs, tissues, body fluids or cells, etc. Prevention, prevention, improvement, treatment of diseases and symptoms in Japan; cardiovascular system (heart, blood vessel, blood / hematopoietic system), Epidemiological system (lymphoid tissue / organ, spleen, thymus), skin, skin appendages, digestive system (lips, tonsils, teeth, esophagus, stomach, small intestine, large intestine, liver, bile duct, spleen), respiratory system ( (Nose, pharynx, larynx, trachea, lungs), urinary system (kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine system (pituitary gland, pineal gland, thyroid gland, adrenal gland), brain, nervous system (Peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism), balance / auditor, visual organ, each mucosal system, motor organs (bone, joint, muscle, tendon, ligament), etc. and various symptoms Prevention, deterioration prevention, improvement, treatment of skin; skin disorders caused by epidermis / dermis, cell disorders, DNA disorders, atopic dermatitis, dry skin symptoms such as dry skin (atopy skin, dry / sozoized skin, aging skin) , Ichthyosis, bulky skin, rough skin, sebum deficiency, xeroderma, dry eczema, progressive Palmokeratosis, erythema, sclerosis / keratinization, cracks, scales, bruises, itching, scarring), spots, buckwheat, pruritus, skin rash, roughness, wrinkles, cracks, redheads, skin aging symptoms (wrinkles, tension, elasticity Reduction, sagging, stains), oily skin, acne, dyschromia, UV-induced skin damage (stains, freckles), photoinflammation, dullness, darkening, physical / chemical skin disorders (cuts, burns, bedsores), water, Skin symptoms caused by the use of soaps, detergents, surfactants, solvents, side effects of pharmaceuticals such as topical skin preparations, biological skin disorders (skin infections), athlete's foot, dermatitis, eczema, wound healing, hair growth, hair restoration Prevention, deterioration prevention, improvement, treatment of hair growth, alopecia, etc .; prevention, deterioration prevention, improvement, treatment of spots, buckwheat, senile pigment spots, etc .; various inflammations, infections, allergies, immune dysfunction, mucosal disorders , Cell damage, DNA Disorder, tumor, ulcer, hyperlipidemia, obesity, diabetes, arteriosclerosis, gout, blood pressure restoration, improvement (high blood pressure, hypotension), blur, dementia, rhinitis, asthma, various symptoms of the eye, cold, blood vessels Disability, internal stiffness, stiff shoulders, lottery, neuralgia, low back pain, rheumatism, hemorrhoids, recovery from fatigue, prepartum cold disease, stomatitis, throat inflammation, pain, sore throat, laryngitis, tonsillitis, periodontitis, alveolar effusion, gingiva Flame, osteoporosis, nutritional tonic, frail constitution, physical fatigue, physical strength reduction, salt damage prevention, Helicobacter pylori growth inhibition, stress, prevention of side effects due to medicines, prevention, improvement, treatment; tumor prevention, prevention of deterioration, improvement; cancer Prevention, deterioration prevention, progress inhibition, metastasis prevention, improvement, treatment; sexual function improvement, improvement, normalization, restoration or prevention of aging, youthfulness retention or rejuvenation can be expected. Furthermore, it is also useful as an organ preservative or cell preservative (for example, used as a medium additive).
In addition, white rice has hardly been developed for new uses other than food. Furthermore, even if white rice is ingested daily as a staple food, there is no direction to regard it as dangerous, and safety has been demonstrated. In other words, the present invention has been found not only to have a very excellent life extension effect, but also to have a sufficiently demonstrated safety, various pharmaceuticals, quasi drugs, cosmetics, foods It can be said that it is a very significant invention that can be used for the above. In addition, it is extremely meaningful to find new uses for rice and to increase consumption by improving the image of rice.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005516915A JP5307969B2 (en) | 2004-01-05 | 2005-01-05 | Life extension agent containing white rice-derived ingredients as active ingredients |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004000636 | 2004-01-05 | ||
JP2004000636 | 2004-01-05 | ||
PCT/JP2005/000261 WO2005065700A1 (en) | 2004-01-05 | 2005-01-05 | Life-prolonging agent comprising polished rice-origin components as the active ingredient |
JP2005516915A JP5307969B2 (en) | 2004-01-05 | 2005-01-05 | Life extension agent containing white rice-derived ingredients as active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2005065700A1 JPWO2005065700A1 (en) | 2007-07-26 |
JP5307969B2 true JP5307969B2 (en) | 2013-10-02 |
Family
ID=34746954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005516915A Active JP5307969B2 (en) | 2004-01-05 | 2005-01-05 | Life extension agent containing white rice-derived ingredients as active ingredients |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5307969B2 (en) |
WO (1) | WO2005065700A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8287925B2 (en) | 2005-07-04 | 2012-10-16 | Takahito Tokuyama | Cell-proliferating agent or tissue-repairing agent derived from white rice |
JP2010252726A (en) * | 2009-04-27 | 2010-11-11 | Kyushu Univ | Method for reinforcing anti-oxidizing activity function of persimmon and health food material |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0741426A (en) * | 1993-05-25 | 1995-02-10 | Soken Kk | Active oxygen scavenger from rice |
JPH07138177A (en) * | 1993-11-12 | 1995-05-30 | Soken Kk | Suppressor for peroxylipid from rice |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06298660A (en) * | 1993-02-19 | 1994-10-25 | Soken Kk | Preventive and therapeutic medicine for cancer produced from rice |
-
2005
- 2005-01-05 JP JP2005516915A patent/JP5307969B2/en active Active
- 2005-01-05 WO PCT/JP2005/000261 patent/WO2005065700A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0741426A (en) * | 1993-05-25 | 1995-02-10 | Soken Kk | Active oxygen scavenger from rice |
JPH07138177A (en) * | 1993-11-12 | 1995-05-30 | Soken Kk | Suppressor for peroxylipid from rice |
Non-Patent Citations (6)
Title |
---|
JPN6010023356; 別冊・医学のあゆみ 第1版第1刷, 2000, pp.26-27 * |
JPN6010023359; 金沢医科大学雑誌 Vol.28 No.3, 2003, pp.169-177 * |
JPN6011015434; Geriatr. Med. Vol.38 No.2, 2000, pp.171-176 |
JPN6011015436; Biol. Pharm. Bull. Vol.25 No.1, 2002, pp.19-23 |
JPN6011015439; Biosci. Biotech. Biochem. Vol.59 No.5, 1995, pp.822-826 |
JPN6011015441; Circulation Vol.105, 2002, pp.2107-2111 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005065700A1 (en) | 2007-07-26 |
WO2005065700A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106794202B (en) | Improve the composition of human skin health and its prepares the purposes in product | |
TWI516280B (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
CN105054076B (en) | A kind of alimentation composition and its application for helping to improve alzheimer's disease | |
JPH05139984A (en) | Active oxygen eliminant from rice | |
CN105596277A (en) | Cactus face cream for treating acne and preparation method thereof | |
JPH05320061A (en) | Active oxygen-eliminating agent produced from bean | |
CN105451712B (en) | Be used to prepare with the reaction platform of the substance based on pollen of beeswax combination and method and application thereof | |
CN109259022A (en) | A kind of drink containing small-molecular peptides that can quickly improve microcirculation function | |
JP5307969B2 (en) | Life extension agent containing white rice-derived ingredients as active ingredients | |
JP5514390B2 (en) | Life extension agent made from cereals and beans other than rice | |
CN115154393B (en) | Aloe fermentation liquor and preparation method and application thereof | |
CN110075280A (en) | A kind of compound oral agents of laminin peptide and preparation method thereof | |
JP4772354B2 (en) | Life extension agent made from rice | |
JP5296957B2 (en) | Anti-aging agent for oral use | |
CN109700832A (en) | Pharmaceutical composition comprising bacillus licheniformis and American-cockroach-extract | |
WO2008023425A1 (en) | Composition for amelioration of skin condition | |
CN105496934A (en) | Cactus mask for treating acne and preparation method | |
JP2008156256A (en) | Oral administration composition | |
CN109363164A (en) | A kind of oral solution and preparation method thereof containing small-molecular peptides that can improve microcirculation | |
JP2006271357A (en) | Amino acid composition | |
CN110740741A (en) | Processed product of purslane, method for producing processed product of purslane, supplement, pharmaceutical, intestinal mucosa protective agent, and intestinal conditioning agent | |
JP5668018B2 (en) | Alcohol intake disorder preventive | |
JP6158147B2 (en) | Whitening agent and internal or external composition containing the same | |
TWI795908B (en) | Preparation method of velvet antler extraction by-product hydrolyzate and its use for treating or preventing bone damage-related diseases | |
CN103070918A (en) | Body moistening oil for removing HPV virus and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071029 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100707 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101110 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20101208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130516 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130628 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5307969 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |